Just won the new wealth best analyst pharmaceutical and biotech industry head Quebec, from China Merchants Securities Zhang Mingfang, in the fifth best analysts of New Wealth Investment Summit and investors to share her for the industry on the latest research results. She believes that as the industry changes, the pharmaceutical industry will enter the golden period of investment.

Zhang Mingfang introduced this year, the pharmaceutical industry is very significant changes, one is the State Food and drug administration leadership change; the two is the implementation of the new drug registration management measures, improve the drug innovation enthusiasm; three is the reform of the medical system is rapidly advancing, the reform would make Medicare drug big expansion, for pharmaceutical commercial enterprises is good.

Zhang Mingfang also introduced some of the industry view. Because in the saturated monopoly, and the market demand to maintain steady growth, she is the most optimistic about the future development of vaccines and blood products, blood products, especially in January 1st next year will be the implementation of the "batch release system, which will increase the doctors and patients for blood products safety and confidence, increase product sales volume.

For the brand of Chinese medicine, Zhang Mingfang believes that the NDRC price controls, to very high growth is difficult to maintain, to health care products and consumer goods extension direction.

She is optimistic about the disease, including cardiovascular medicine varieties, anticancer and endocrine modulators. Investors can grasp the industry in the asset injection and the overall market will bring investment opportunities.

The report hall to provide you with more: